In lung cancer, PRMT5 activity increases FGFR3 expression by repressing miR-99, and in AML (acute myeloid leukemia) PRMT5 repression of miR-29b upregulates FLT3 [22–24]. The gene discussed is PRMT5; the disease is lung carcinoma.